Singapore, Oct. 1 -- The Association for the Advancement of Blood & Biotherapies (AABB) has published a special supplemental issue of its peer-reviewed journal, TRANSFUSION, focused on biotherapies.

The supplement reflects AABB's expanding role in biotherapies and the connections between transfusion medicine and the advancement of these therapies.

The August supplement will be made freely accessible for 24 months following publication.

The publication is supported by Vitalant, one of the nation's largest nonprofit blood and biotherapies healthcare organisations, and reflects growing coordination between transfusion medicine and advanced therapies as healthcare organisations prepare for broader clinical adoption of cell and gene therapi...